PT - JOURNAL ARTICLE AU - Schenk, A AU - Esser, T AU - Belen, S AU - Gunasekara, N AU - Joisten, N AU - Winker, M AU - Weike, L AU - Bloch, W AU - Heidenreich, A AU - Herden, J AU - Löser, H AU - Oganesian, S AU - Theurich, S AU - Watzl, C AU - Zimmer, P TI - Acute exercise induces natural killer cell mobilization but not infiltration into prostate cancer tissue in humans AID - 10.1101/2022.04.28.22274307 DP - 2022 Jan 01 TA - medRxiv PG - 2022.04.28.22274307 4099 - http://medrxiv.org/content/early/2022/05/02/2022.04.28.22274307.short 4100 - http://medrxiv.org/content/early/2022/05/02/2022.04.28.22274307.full AB - The mobilization and activation of natural killer (NK) cells have been proposed as key mechanisms promoting anti oncogenic effects of physical exercise. Although mouse models have proven that physical exercise recruits NK cells to tumor tissue and inhibits tumor growth, this preclinical finding has not been transferred to the clinical setting yet. In this first-in-human study, we found that physical exercise mobilizes and redistributes NK cells, especially those with a cytotoxic phenotype, in line with preclinical models. However, physical exercise did not increase NK cell tumor infiltrates. Future studies should carefully distinguish between acute and chronic exercise modalities and should be encouraged to investigate more immune responsive tumor entities.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialGerman Clinical Trials Register DRKS00010442Funding StatementThis study was funded by internal grants of the German Sport University Cologne.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Commission of Cologne University Faculty of Medicine. See attached files. Approval was granted by the above-mentioned ethics committee with ethics motion no. 064/2016 and titled "Influence of a single endurance load on epigenetic modifications, effector function, and tumor infiltration of natural killer cells" on May 10, 2016.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.